The United Laboratories International Holdings Limited is an investment holding company. It is organized into three revenue streams: sale of intermediate products (Intermediate products), sale of bulk medicine (Bulk medicine) and sale of antibiotics finished products, nonantibiotics finished products and capsule casings (together Finished products). It engages in producing and sale of finished pharmaceutical products, bulk medicine, intermediate products and capsules. The products being sold in the People鈥檚 Republic of China are finished products, bulk medicine, intermediate products and capsule casings. Finished products include eight series and more than 50 products, relating to several medical fields, including antibiotics, antipyretic analgesic, anti-allergy and antihepatitis B andcardiovascular drugs. Bulk medicine includes four series and more than 30 products. It has eight imported automatic production lines, which can produce a range of medical capsule casings.